These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 38084409
1. Anoctamin-1 is induced by TGF-β and contributes to lung myofibroblast differentiation. Reed EB, Orbeta S, Miao BA, Sitikov A, Chen B, Levitan I, Solway J, Mutlu GM, Fang Y, Mongin AA, Dulin NO. Am J Physiol Lung Cell Mol Physiol; 2024 Jan 01; 326(1):L111-L123. PubMed ID: 38084409 [Abstract] [Full Text] [Related]
2. Anoctamin-1 is induced by TGF-beta and contributes to lung myofibroblast differentiation. Reed EB, Orbeta S, Miao BA, Sitikov A, Chen B, Levitan I, Solway J, Mutlu GM, Fang Y, Mongin AA, Dulin NO. bioRxiv; 2023 Nov 09. PubMed ID: 37333255 [Abstract] [Full Text] [Related]
3. TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression. Huang Y, Xie Y, Abel PW, Wei P, Plowman J, Toews ML, Strah H, Siddique A, Bailey KL, Tu Y. Biochem Pharmacol; 2020 Oct 09; 180():114172. PubMed ID: 32712053 [Abstract] [Full Text] [Related]
4. MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation. Guo X, Adeyanju O, Olajuyin AM, Mandlem V, Sunil C, Adewumi J, Huang S, Tucker TA, Idell S, Qian G. Am J Physiol Cell Physiol; 2023 Nov 01; 325(5):C1190-C1200. PubMed ID: 37661917 [Abstract] [Full Text] [Related]
5. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway. Dai WJ, Qiu J, Sun J, Ma CL, Huang N, Jiang Y, Zeng J, Ren BC, Li WC, Li YH. J Cell Physiol; 2019 Mar 01; 234(3):2552-2565. PubMed ID: 30144053 [Abstract] [Full Text] [Related]
6. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Wei P, Xie Y, Abel PW, Huang Y, Ma Q, Li L, Hao J, Wolff DW, Wei T, Tu Y. Cell Death Dis; 2019 Sep 11; 10(9):670. PubMed ID: 31511493 [Abstract] [Full Text] [Related]
7. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts. Dubey S, Dubey PK, Umeshappa CS, Ghebre YT, Krishnamurthy P. J Cell Physiol; 2022 Apr 11; 237(4):2169-2182. PubMed ID: 35048404 [Abstract] [Full Text] [Related]
8. Effects of the Calcium-Activated Chloride Channel Inhibitors T16Ainh-A01 and CaCCinh-A01 on Cardiac Fibroblast Function. Tian XQ, Ma KT, Wang XW, Wang Y, Guo ZK, Si JQ. Cell Physiol Biochem; 2018 Apr 11; 49(2):706-716. PubMed ID: 30165368 [Abstract] [Full Text] [Related]
9. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition. Guo X, Adeyanju O, Sunil C, Mandlem V, Olajuyin A, Huang S, Chen SY, Idell S, Tucker TA, Qian G. Am J Physiol Cell Physiol; 2022 Jul 01; 323(1):C133-C144. PubMed ID: 35584329 [Abstract] [Full Text] [Related]
10. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts. Zhang Q, Tu W, Tian K, Han L, Wang Q, Chen P, Zhou X. J Cell Biochem; 2019 Jan 01; 120(1):93-104. PubMed ID: 30230565 [Abstract] [Full Text] [Related]
11. Cub domain-containing protein 1 negatively regulates TGF-β signaling and myofibroblast differentiation. Noskovičová N, Heinzelmann K, Burgstaller G, Behr J, Eickelberg O. Am J Physiol Lung Cell Mol Physiol; 2018 May 01; 314(5):L695-L707. PubMed ID: 29351434 [Abstract] [Full Text] [Related]
13. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production. Al-Habeeb F, Aloufi N, Traboulsi H, Liu X, Nair P, Haston C, Azuelos I, Huang SK, White ES, Gallouzi IE, Di Marco S, Eidelman DH, Baglole CJ. J Cell Physiol; 2021 Oct 01; 236(10):6836-6851. PubMed ID: 33855709 [Abstract] [Full Text] [Related]
14. The Novel mTOR Complex 1/2 Inhibitor P529 Inhibits Human Lung Myofibroblast Differentiation. Ferguson KT, Torr EE, Bernau K, Leet J, Sherris D, Sandbo N. J Cell Biochem; 2017 Aug 01; 118(8):2241-2249. PubMed ID: 28078713 [Abstract] [Full Text] [Related]
15. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis. Kurumiya E, Iwata M, Kasuya Y, Tatsumi K, Honda T, Murayama T, Nakamura H. Eur J Pharmacol; 2024 Mar 05; 966():176366. PubMed ID: 38296153 [Abstract] [Full Text] [Related]
16. Metformin attenuates lung fibrosis development via NOX4 suppression. Sato N, Takasaka N, Yoshida M, Tsubouchi K, Minagawa S, Araya J, Saito N, Fujita Y, Kurita Y, Kobayashi K, Ito S, Hara H, Kadota T, Yanagisawa H, Hashimoto M, Utsumi H, Wakui H, Kojima J, Numata T, Kaneko Y, Odaka M, Morikawa T, Nakayama K, Kohrogi H, Kuwano K. Respir Res; 2016 Aug 30; 17(1):107. PubMed ID: 27576730 [Abstract] [Full Text] [Related]
17. Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease. Harris WT, Kelly DR, Zhou Y, Wang D, MacEwen M, Hagood JS, Clancy JP, Ambalavanan N, Sorscher EJ. PLoS One; 2013 Aug 30; 8(8):e70196. PubMed ID: 23950911 [Abstract] [Full Text] [Related]
18. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis. Xiao X, Senavirathna LK, Gou X, Huang C, Liang Y, Liu L. Physiol Rep; 2016 Sep 30; 4(17):. PubMed ID: 27582065 [Abstract] [Full Text] [Related]